Lumbosacral Radiculopathy Clinical Trial
Official title:
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study (A Phase 1/2a, First-in-Human, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Therapeutic Activity of Single Ascending Doses of KLS-2031 Administered by Transforaminal Epidural Injection in Patients With Neuropathic Pain From Lumbosacral Radiculopathy)
Verified date | November 2022 |
Source | Kolon Life Science |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
Status | Enrolling by invitation |
Enrollment | 8 |
Est. completion date | April 30, 2027 |
Est. primary completion date | October 30, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria : To be considered eligible to participate in this study, a patient must meet the inclusion criteria listed below: 1. Patients that have completed the KS-GIG-001-01 Study and were in the Active Treatment group 2. Patients having signed the consent forms for both the KS-GIG-001-01 Study and this Long Term, 3-Year Follow-up Study Exclusion Criteria : To be eligible for entry into the study, the patient must not meet any of the exclusion criteria listed below: 1. Enrollment in another AAV or other gene therapy trial |
Country | Name | City | State |
---|---|---|---|
United States | Kolon Investigative Site : CenExel JBR | Salt Lake City | Utah |
Lead Sponsor | Collaborator |
---|---|
Kolon Life Science |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Long-term safety of previous treatment as assessed by frequency and nature of adverse events (AEs) | Baseline through end of study (approximately 3 years) | ||
Secondary | Change from baseline to each visit in Pain Intensity Numerical Rating Scale (PI-NRS) score = Result at week n - baseline, (n=52, 104, 156) | The PI-NRS is measured on an 11-point numerical scale ranging from 0 (no pain) to 10 (worst possible pain) that the patient selects to best describe the intensity of pain that they have experienced in the last 24 hours. | Week 52, Week 104, Week 156 | |
Secondary | Change from baseline to each visit in Daily Sleep Interference Scale (DSIS) score = Result at week n - baseline, (n=52, 104, 156) | The DSIS has an 11-point numerical scale that asks the patient to assess how pain has interfered with their sleep during the past 24 hours. Response options range from 0 (does not interfere with sleep) to 10 (completely interferes with sleep). | Week 52, Week 104, Week 156 | |
Secondary | Change from baseline to each visit in Galer Neuropathic Pain Scale (Galer NPS) score = Result at week n - baseline, (n=52, 104, 156) | The Galer NPS is a relatively simple, self-administered, 10-item questionnaire for evaluating pain, which assesses distinct pain qualities associated with neuropathic pain. | Week 52, Week 104, Week 156 | |
Secondary | Change from baseline to each visit in modified Roland-Morris Disability Questionnaire (RMDQ) score = Result at week n - baseline, (n=52, 104, 156) | The modified RMDQ is a self-administered, 24-question physical disability measurement tool that evaluates both back and leg pain. Each of the 24 questions is asked 2 times, once with regard to back pain and once with regard to leg pain, for a total of 48 items. Each question requires a "yes" or "no" answer; 1 point is scored for each positive response. The total scores are determined on a scale of 0 to 24 for back pain and on a scale of 0 to 24 for leg pain, with 0 representing "no disability" and 24 representing "extreme disability." | Week 52, Week 104, Week 156 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05654428 -
Effects of Mackenzie Extension and William Flexion Exercises in Lumbo-sarcal Radiculopathy
|
N/A | |
Terminated |
NCT01267825 -
CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial
|
Phase 4 | |
Completed |
NCT02935608 -
Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy
|
Phase 2 | |
Completed |
NCT03727100 -
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
|
Phase 3 | |
Terminated |
NCT02951377 -
Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy
|
Phase 1 | |
Completed |
NCT03776318 -
Long-Term Follow-up Safety of Clonidine Micropellets
|
||
Active, not recruiting |
NCT04238793 -
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
|
Phase 1/Phase 2 | |
Terminated |
NCT05614648 -
Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet
|
Phase 3 | |
Completed |
NCT06058806 -
Effects of Multimodal Physical Therapy in Patients With Lumbosacral Radiculopathy
|
N/A | |
Completed |
NCT01917825 -
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
|
Phase 2 | |
Recruiting |
NCT06167044 -
Effect of Thoracic Mobilization on Lumbar Radiculopathy
|
N/A | |
Completed |
NCT00826124 -
Does Magnetic Resonance Imaging (MRI) Improve Interventional Outcomes for Lumbosacral Radiculopathy?
|
N/A | |
Recruiting |
NCT06216288 -
Effect of Combined Lumbar Traction and Repetitive Back Extension Exercise on H-reflex in Lumbosacral Radiculopathy
|
N/A | |
Completed |
NCT04778592 -
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
|
Phase 2 | |
Recruiting |
NCT05711121 -
Caudal Versus S1 Transforaminal Epidural Steroid Injection for the Treatment of Unilateral S1 Radiculopathy
|
N/A | |
Terminated |
NCT03514277 -
A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief
|
Phase 4 | |
Completed |
NCT01655849 -
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
|
Phase 2 | |
Terminated |
NCT01836770 -
Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
|
N/A | |
Completed |
NCT00733096 -
A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy
|
Phase 2/Phase 3 | |
Completed |
NCT01561027 -
Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
|
Phase 2 |